Debate: A Case Of Relapsed Peripheral T-Cell Lymphoma - Sequential Novel Agents

Debate: A Case of Relapsed Peripheral T-Cell Lymphoma - Sequential novel agents

Debate: A Case of Relapsed Peripheral T-Cell Lymphoma - Stem Cell Transplant

Understanding Peripheral T-Cell Lymphoma with Dr. Pamela Blair Allen

Lymphoma Research Foundation

Debate: Hodgkin lymphoma patient who relapses after autologous SCT - Serial novel agents

Debate: What is the best approach for relapsed T cell lymphoma? - AlloSCT

Phase 3 Study Peripheral T-Cell Lymphoma: Alisertib Versus Investigator’s Choice

MPNUniversity .tv

iwNHL 2015 roundtable: Novel therapeutic combinations for relapsed/refractory T-cell lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Debate: Hodgkin lymphoma patient who relapses after autologous SCT - Allogeneic SCT

Peripheral T-Cell Lymphoma: What is New on the Horizon?

Improved outcomes in PTCL with the use of novel agents and transplantation

VJHemOnc – Video Journal of Hematology & HemOnc

Novel Treatment Strategies for Peripheral T-cell Lymphomas

Understanding Peripheral T-Cell Lymphoma with Pierluigi Porcu, MD

Lymphoma Research Foundation

Debate: Relapsed 60 y/o Follicular lymphoma patient after upfront R-CHOP - Novel agents

The current standard of care for patients with PTCL

VJHemOnc – Video Journal of Hematology & HemOnc

Peripheral T-Cell Lymphomas: Confusion in a Perplexing Disease

What is the Best Approach to the Initial Therapy of Peripheral T-cell Lymphoma?

Dr. Foss on Tipifarnib in Relapsed, Refractory, T-Cell Lymphoma

Blood Cancers Today

Debate: Young patient with recurrent follicular lymphoma and short remission? - Novel agents/chemo